Return
PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma
S
Y
J
W
J
G
X
K
Y
S
Y
Y
Q
Y
J
P
S
S
J
C
DOI:10.1016/j.ccell.2026.06.010.png)
Abstract
En 中文
• Anti-PD-1 therapy unleashes local B cell response targeting Hepatitis B core antigen • Extracellular HBcAg is a tumor hallmark in resectable HBV-related HCCs • Developed a method to visualize antibody affinity enhancement within tumor TLSs in situ • Anti-HBcAg enhanced anti-PD-1 therapy efficacy via C1q-dependent mechanism in HCC
Journal
IF:
44.5
Papers:
413
Citations:
5.6W
Organization
No organization information available
